TP ICAP downed by Macquarie, but Exane BNP gives Man Group a lift
A look at some of the top risers and fallers in London in afternoon trading
Company
ReNeuron Group PLC
LON:RENE
ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.
298 stories · page 11 of 15
ReNeuron presents more data on potential for its Exosome therapy as cancer treatment
“This work has the potential to uncover a whole new area in cancer therapeutics"
FTSE 100 closes in negative territory as pound strengthens
The FTSE 100 index closed 14.98 down at 7,507, above the day’s low of 7,496.14, and well below the opening high of 7,523.65
Archive
Proactive news snapshot: Synairgen, Silence Therapeutics, LoopUp Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Cyber security firm Shearwater soars as chairman increases holding
Sports Direct, Barratt Developments, Ryanair and EasyJet were among Wednesday's early market movers.
ReNeuron Group's therapeutic programme progressing to plan
In an update ahead of the company’s annual meeting it confirmed it is putting the finishing touches to data packages that will be submitted as part of its application to start a US Phase III clinical trial using its CTX cells to treat strok
Archive
Proactive news snapshot: ITM Power, eg solutions, Haydale Graphene Industries …
A glance at some of the day's highlights from the Proactive Investors newswire
FTSE 100 closes higher despite US jobs data; FTSE 250 lags
London's blue-chip benchmark was holding positive ground, even though US employment figures for August fell short of expectations.
Archive
Proactive news round-up: Sirius Minerals , Seeing Machines, Greatland Gold...
A glance at some of the small cap stories on the Proactive newswire today
London Capital Group shares drop as 2016 results hit by Brexit uncertainty
A look at the biggest risers and fallers of London's small caps
ReNeuron Group upbeat as it progresses on all stem cell fronts
“The unmet medical need in chronic stroke disability is enormous"
Archive
Dixons Carphone still proving resilient on UK High Street
Week ahead: Dixons to show resilience, Bank of England maybe less so
Archive
Proactive end of day round-up: Amur Minerals; 88 Energy; Mosman Oil & Gas ..
A glance at some of the the small cap news on the Proactive newswire today
Fusionex shares rebound amid backlash from Standard Life on plans to cancel AIM listing
A look at the biggest risers and fallers in London today
ReNeuron set the broaden scope of eye disease research after regulatory sign-off for frozen cell line
The US Food & Drug Administration (FDA) green light means its human retinal progenitor cells (hRPC) can be frozen for shipping and storage and thawed at the point of use.
Investments and investor services
FTSE 100 ends higher on day Brexit negotiations begin
The FTSE 100 closed 60 points up at 7,523 as the government begins Brexit negotiations.
Archive
Proactive news round-up: Sirius Minerals, Green Dragon Gas, Reneuron ...
A glance at some of the stories on the Proactive newswire today
Powerhouse Energy energised by up to £500,000 funding deal
Some of the main risers and fallers in London at 3.45pm